|
29/09/2025
|
07:00
|
Directorate Changes
|
RNS
|
|
25/09/2025
|
07:00
|
Interim results for the six months to 30 June 2025
|
RNS
|
|
25/09/2025
|
07:00
|
Co-Development Agreement & Monetisation Deal
|
RNS
|
|
24/09/2025
|
09:30
|
Notice of Interim Results
|
RNS
|
|
04/09/2025
|
07:00
|
Positive FDA Feedback on Phase 2 Study Design
|
RNS
|
|
28/08/2025
|
12:00
|
Holding(s) in Company
|
RNS
|
|
08/08/2025
|
07:00
|
Change of Auditor
|
RNS
|
|
14/07/2025
|
07:00
|
Arecor Establishes New Scientific Advisory Board
|
RNS
|
|
04/06/2025
|
07:00
|
Grant of Options and PDMR Dealing
|
RNS
|
|
02/06/2025
|
13:32
|
Result of AGM
|
RNS
|
|
02/06/2025
|
07:00
|
Non-Executive Director Board Change
|
RNS
|
|
21/05/2025
|
07:00
|
Director/PDMR Dealing
|
RNS
|
|
19/05/2025
|
07:00
|
Arecor Partnership with Skye Bioscience
|
RNS
|
|
14/05/2025
|
14:37
|
Director Dealing
|
RNS
|
|
08/05/2025
|
07:00
|
Arecor sells rights to non-Ogluo® products
|
RNS
|
|
06/05/2025
|
16:42
|
Posting of 2024 Annual Report and Notice of AGM
|
RNS
|
|
24/04/2025
|
07:00
|
Arecor to present on Investor Meet Company
|
RNS
|
|
23/04/2025
|
07:00
|
Grant of Options and PDMR Dealing
|
RNS
|
|
22/04/2025
|
07:00
|
Final results for 2024
|
RNS
|
|
10/04/2025
|
07:00
|
Notice of Results
|
RNS
|
|
26/03/2025
|
07:00
|
Collaboration with global pharmaceutical partner
|
RNS
|
|
12/03/2025
|
07:00
|
Arecor partnership with biopharmaceutical company
|
RNS
|
|
03/02/2025
|
07:00
|
Arecor Full Year 2024 Trading Update
|
RNS
|
|
10/01/2025
|
07:45
|
Orderly Cessation of Tetris Pharma Operations
|
RNS
|
|
09/01/2025
|
07:00
|
Change of Nominated Advisor and Joint Broker
|
RNS
|
|
30/12/2024
|
07:00
|
Arecor Signs Exclusive Licensing Agreement
|
RNS
|
|
02/12/2024
|
07:00
|
Grant of Options and PDMR Dealing
|
RNS
|
|
18/11/2024
|
07:00
|
Arecor Appoints Interim Chief Financial Officer
|
RNS
|
|
26/09/2024
|
07:00
|
Interim Results for six months ended 30 June 2024
|
RNS
|
|
19/09/2024
|
15:17
|
Notice of Results
|
RNS
|
|
11/09/2024
|
07:00
|
Arecor presents positive AT278 data at EASD
|
RNS
|
|
22/08/2024
|
16:34
|
Holding(s) in Company
|
RNS
|
|
20/08/2024
|
13:44
|
Holding(s) in Company
|
RNS
|
|
12/08/2024
|
15:02
|
Holding(s) in Company
|
RNS
|
|
08/08/2024
|
14:48
|
Result of General Meeting and Total Voting Rights
|
RNS
|
|
23/07/2024
|
16:26
|
Posting of Circular and General Meeting
|
RNS
|
|
23/07/2024
|
07:00
|
Result of WRAP Retail Offer
|
RNS
|
|
19/07/2024
|
18:22
|
Result of Placing and Subscription
|
RNS
|
|
19/07/2024
|
13:17
|
WRAP Retail Offer to raise up to £1 million
|
RNS
|
|
19/07/2024
|
13:10
|
Proposed Placing and Subscription
|
RNS
|
|
28/06/2024
|
14:35
|
Result of AGM
|
RNS
|
|
10/06/2024
|
07:00
|
Trading and Funding Update
|
RNS
|
|
31/05/2024
|
16:05
|
Posting of 2023 Annual Report and Notice of AGM
|
RNS
|
|
23/05/2024
|
07:00
|
Grant of Options and PDMR Dealing
|
RNS
|
|
21/05/2024
|
07:00
|
Arecor to host company and KOL webinar today
|
RNS
|
|
20/05/2024
|
07:00
|
Positive headline results for AT278 clinical trial
|
RNS
|
|
16/05/2024
|
07:00
|
Final results for 2023
|
RNS
|
|
14/05/2024
|
10:17
|
Notice of Results
|
RNS
|
|
09/05/2024
|
07:00
|
Arecor and Medtronic Diabetes collaboration
|
RNS
|
|
03/05/2024
|
16:44
|
Publication of Full Year Financial Results delayed
|
RNS
|